Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status

International Journal of Antimicrobial Agents

Volumn 55, Issue 4, 2020, Pages

  Lai, Chih Cheng ^a   Wang, Cheng Yi ^b   Wang, Ya Hui ^b   Hsueh, Shun Chung ^c   Ko, Wen Chien ^d   Hsueh, Po Ren ^e  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coronavirus disease 2019; Country healthcare resources; COVID 19; Daily cumulative index; Disease incidence; Mortality

Indexed keywords

ARTICLE; CHINA; CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; CORRELATIONAL STUDY; CUMULATIVE SCALE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE TRANSMISSION; ECONOMIC STATUS; EPIDEMIOLOGICAL DATA; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; INFECTION CONTROL; MORBIDITY; MORTALITY RATE; PATIENT EDUCATION; PATIENT MONITORING; PRIORITY JOURNAL; SARS-RELATED CORONAVIRUS; TAIWAN; TRAVEL; BETACORONAVIRUS; ECONOMICS; HEALTH CARE PLANNING; INDIA; IRAN; ITALY; JAPAN; MEDICAL GEOGRAPHY; MORTALITY; PANDEMIC; SOUTH KOREA; VIRUS PNEUMONIA;

BETACORONAVIRUS; CHINA; CORONAVIRUS INFECTIONS; GEOGRAPHY, MEDICAL; HEALTH RESOURCES; HUMANS; INCIDENCE; INDIA; IRAN; ITALY; JAPAN; PANDEMICS; PNEUMONIA, VIRAL; REPUBLIC OF KOREA; TAIWAN;

EID: 85082511011     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2020.105946     Document Type: Article

References (10)

1. World Health Organization (WHO). Coronavirus disease 2019 (COVD-19). Situation report – 40., 2020, WHO, Geneva, Switzerland Data as reported by 10AM CET 29 February 2020 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200229-sitrep-40-covid-19.pdf?sfvrsn=849d0665_2 [accessed 17 March 2020].
2. Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020 Feb 28, 10.1056/NEJMoa2002032 [Epub ahead of print].
3. Lai, C.C., Shih, T.P., Ko, W.C., Tang, H.J., Hsueh, P.R., Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents, 55, 2020, 105924, 10.1016/j.ijantimicag.2020.105924.
4. Lai, C.C., Liu, Y.H., Wang, C.Y., Wang, Y.H., Hsueh, S.C., Yen, M.Y., et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): facts and myths. J Microbiol Immunol Infect, 2020 March 4, 10.1016/j.jmii.2020.02.012.
5. Wu, Z., McGoogan, J.M., Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA, 2020 Feb 24, 10.1001/jama.2020.2648 [Epub ahead of print].
6. Rocklov, J., Sjodin, H., Wilder-Smith, A., COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures. J Travel Med, 2020 Feb 28, 10.1093/jtm/taaa030 pii: taaa030 [Epub ahead of print].
7. Wang, C.J., Ng, C.Y., Brook, R.H., Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing. JAMA, 2020 Mar 3, 10.1001/jama.2020.3151 [Epub ahead of print].
8. Ji, Y.M.Z., Peppelenbosch, M.P., Pan, Q., Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob Health, 2020 February 25, 10.1016/S2214-109X(20)30068-1 [Epub ahead of print].
9. Health Care Index by country 2020. https://www.numbeo.com/health-care/rankings_by_country.jsp[accessed 1 March 2020].
10. GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet 391 (2018), 2236–2271, 10.1016/S0140-6736(18)30994-2.